首页 | 本学科首页   官方微博 | 高级检索  
检索        


Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
Authors:S Peters  J-L Pujol  U Dafni  M Dómine  S Popat  M Reck  J Andrade  A Becker  D Moro-Sibilot  A Curioni-Fontecedro  O Molinier  K Nackaerts  A Insa Mollá  R Gervais  G López Vivanco  J Madelaine  J Mazieres  M Faehling  R Califano
Institution:1. Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland;2. Lausanne University, Lausanne, Switzerland;3. Thoracic Oncology Unit, Hopital Arnaud de Villeneuve, Montpellier, France;4. National and Kapodistrian University of Athens, Athens, Greece;5. Frontier Science Foundation-Hellas, Athens, Greece;6. Hospital Universitario Fundacion Jimenez Díaz (IIS-FJD), Madrid, Spain;7. Medicine, Royal Marsden Hospital, London, UK;8. Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany;9. Medical Oncology, Hospital Virgen De La Salud, Toledo, Spain;10. Department of Pulmonology, Amsterdam University Medical Center, Amsterdam, the Netherlands;11. Thoracic Oncology Unit, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France;12. Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland;13. Department of Respiratory Disease, Centre Hospitalier – Le Mans, Le Mans, France;14. Department of Pulmonology, Respiratory Oncology Unit, KU Leuven, Leuven, Belgium;15. Medical Oncology, Hospital Clínico Universitario De Valencia, Valencia, Spain;16. Medical Oncology, Centre François Baclesse, Caen, France;17. Medical Oncology, Hospital Universitario Cruces, Barakaldo, Spain;18. Thoracic Oncology Unit, Centre Hospitalier Universitaire Caen Normandie, Caen, France;19. Thoracic Oncology, Centre Hospitalier Universitaire Toulouse, Toulouse, France;20. Klinikum Esslingen, Esslingen, Germany;21. Pius-Hospital Oldenburg, Oldenburg, Germany;22. Hospital De La Santa Creu I Sant Pau, Barcelona, Spain;23. Hospital Clínico San Carlos, Madrid, Spain;24. Hospital Puerta de Hierro, Madrid, Spain;25. Coordinating Office, European Thoracic Oncology Platform, Bern, Switzerland;26. Olivia Newton-John Cancer Centre, Austin Hospital (VIC), Melbourne, Australia;27. Department of Radiation Oncology, Gustave Roussy, Villejuif, France;28. Maastricht University Medical Center, Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht, Netherlands
Abstract:
Keywords:nivolumab  ipilimumab  small-cell lung cancer  SCLC  limited disease  randomised clinical trial
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号